![Bob Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bob Huang
Direttore/Membro del Consiglio presso
Travecta Therapeutics Pte Ltd.
Profilo
Bob Huang is currently the Director at Travecta Therapeutics Pte Ltd. and Investment Director at Seidler Equity Australia.
He holds a doctorate from The University of New South Wales and an MBA from The Wharton School of the University of Pennsylvania.
Posizioni attive di Bob Huang
| Società | Posizione | Inizio |
|---|---|---|
Seidler Equity Australia
 Seidler Equity Australia Investment ManagersFinance Acts as an alternative investment manager | Investitore di Private Equity | 01/01/2017 |
Travecta Therapeutics Pte Ltd.
 Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Develops a novel chemistry platform for delivery of therapies to the brain | Direttore/Membro del Consiglio | 27/10/2021 |
Formazione di Bob Huang
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
14
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Travecta Therapeutics Pte Ltd.
Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Develops a novel chemistry platform for delivery of therapies to the brain | Technology Services |
Seidler Equity Australia
Seidler Equity Australia Investment ManagersFinance Acts as an alternative investment manager | Finance |
